The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing subjectivity into what should be an objective process.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In genetic analysis, there are often competing explanations for the same data. Sophisticated mathematical models have been developed that can encapsulate these problems in terms of parameters that ...